borderline significantP = .05
Among obese subjects, p.P12A carriers showed significantly higher level of plasma total cholesterol (232.2 ± 41.8 versus 197.1 ± 52.7 mg/dL, P = .02) and tended with a borderline significant to have lower plasma glucose than those with P12P genotype ( P = .05).